Utilization of personalized tumor-specific methylation haplotypes of circulating DNA to monitor minimal residual disease in patients with hepatocellular carcinoma undergoing curative resection

被引：0
|
作者：
Yang, Xin-Rong
Guo, De-Zhen
Zhang, Shi-Yu
Xu, Min-Jie
Chen, Hua
Ma, Cheng-Cheng
Fu, Rui-Qing
Su, Ming-Yang
He, Qi-Ye
Zhang, Yun-Zhi
Su, Zhi-Xi
Liu, Rui
Fan, Jia
Zhou, Jian
机构：
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
[3] Singlera Genom Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16245
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of dynamic circulating tumor DNA minimal residual disease detection on recurrence surveillance and second resection rate after curative intent resection of colorectal liver metastasis: A prospective cohort study.
    Li, Yaqi
    Xu, Jing
    Chen, Yikuan
    Ma, Xiaoji
    Hu, Xiang
    Chen, Yun
    Sun, Lei
    Wu, Huizi
    Xiu, Zhihui
    Dong, Qiduo
    Chen, Lin
    Liu, Jun
    Cai, Sanjun
    Peng, Junjie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 242 - 242
  • [42] The application of circulating tumor DNA analysis for detecting minimal residual disease and predicting recurrence in colorectal cancer patients
    Chan, Hiu Ting
    Nagayama, Satoshi
    Chin, Yoon Ming
    Hayashi, Rie
    Kiyotani, Kazuma
    Nakamura, Yusuke
    Low, Siew-Kee
    CANCER RESEARCH, 2019, 79 (13)
  • [43] Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications
    Akaike, Tomoko
    Thakuria, Manisha
    Silk, Ann W.
    Hippe, Daniel S.
    Park, Song Youn
    So, Naomi A.
    Maloney, Nolan J.
    Gunnell, Lindsay
    Eschholz, Alec
    Kim, Emily Y.
    Sinha, Sumi
    Hall, Evan Thomas
    Bhatia, Shailender
    Reddy, Sunil
    Rodriguez, Angel Augusto
    Aleshin, Alexey
    Choi, Jacob S.
    Tsai, Kenneth Y.
    Yom, Sue S.
    Yu, Siegrid S.
    Choi, Jaehyuk
    Chandra, Sunandana
    Nghiem, Paul
    Zaba, Lisa C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (26)
  • [44] Utilization of circulating tumor DNA (ctDNA) analysis to detect minimal residual disease post-surgery and disease progression in metastatic thymic tumors
    Ardeshir-Larijani, Fatemeh
    Ravichandran, Karthik Raja
    Schneider, Bryan P.
    Radovich, Milan
    Maniar, Rohan
    Masood, Ashiq
    Kesler, Kenneth
    Loehrer, Patrick J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease A Phase 2 Trial
    Jain, Nitin
    Reuben, James M.
    Kantarjian, Hagop
    Li, Changping
    Gao, Hui
    Lee, Bang-Ning
    Cohen, Evan N.
    Ebarb, Theresa
    Scheinberg, David A.
    Cortes, Jorge
    CANCER, 2009, 115 (17) : 3924 - 3934
  • [46] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
    Tie, Jeanne
    Wang, Yuxuan
    Cohen, Joshua
    Li, Lu
    Hong, Wei
    Christie, Michael
    Wong, Hui Li
    Kosmider, Suzanne
    Wong, Rachel
    Thomson, Benjamin
    Choi, Julian
    Fox, Adrian
    Field, Kathryn
    Burge, Matthew
    Shannon, Jenny
    Kotasek, Dusan
    Tebbutt, Niall C.
    Karapetis, Christos
    Underhill, Craig
    Haydon, Andrew
    Schaeffer, Joy
    Ptak, Janine
    Tomasetti, Cristian
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    PLOS MEDICINE, 2021, 18 (05)
  • [48] Effects of branched-chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial
    Hachiya, Hiroyuki
    Aoki, Taku
    Iso, Yukihiro
    Shimizu, Takayuki
    Tago, Kazuma
    Park, Kyung Hwa
    Sakuraoka, Yuhki
    Shiraki, Takayuki
    Mori, Shozo
    Kubota, Keiichi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2020, 27 (11) : 819 - 829
  • [49] Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
    Parikh, Aparna R.
    Van Seventer, Emily E.
    Siravegna, Giulia
    Hartwig, Anna, V
    Jaimovich, Ariel
    He, Yupeng
    Kanter, Katie
    Fish, Madeleine G.
    Fosbenner, Kathryn D.
    Miao, Benchun
    Phillips, Susannah
    Carmichael, John H.
    Sharma, Nihaarika
    Jarnagin, Joy
    Baiev, Islam
    Shah, Yojan S.
    Fetter, Isobel J.
    Shahzade, Heather A.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Dubois, Jon S.
    Franses, Joseph W.
    Giantonio, Bruce J.
    Goyal, Lipika
    Klempner, Samuel J.
    Nipp, Ryan D.
    Roeland, Eric J.
    Ryan, David P.
    Weekes, Colin D.
    Wo, Jennifer Y.
    Hong, Theodore S.
    Bordeianou, Liliana
    Ferrone, Cristina R.
    Qadan, Motaz
    Kunitake, Hiroko
    Berger, David
    Ricciardi, Rocco
    Cusack, James C.
    Raymond, Victoria M.
    Talasaz, AmirAli
    Boland, Genevieve M.
    Corcoran, Ryan B.
    CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5586 - 5594
  • [50] Circulating tumor DNA analysis to detect minimal residual disease and predict recurrence in patients with resectable pancreatic cancer.
    Yang, Liu
    Jiang, Jiahong
    Ye, Song
    Xu, Yaping
    Huang, Dongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345